B Birkedal‐Hansen
- Cancer Research top 0.5%
- Protease and Inhibitor Mechanisms 19
- Periodontics top 0.5%
- Oral microbiology and periodontitis research 2
- Immunology and Allergy top 1%
- Hematology top 1%
- Oncology top 2%
- Peptidase Inhibition and Analysis 12
-
- Enzyme Production and Characterization 6
-
- Oral and gingival health research 5
-
- Bone and Dental Protein Studies 3
-
- Signaling Pathways in Disease 2
-
- Connective tissue disorders research 2
- Co-authors
- Henning Birkedal‐HansenL. Jack WindsorMalena BoddenJeffrey A. EnglerWilliam G. I. MooreArthur A. DeCarloJ. Guy LyonsGregory J. Harber
- Partner nations
- United StatesAustraliaDenmark
In The Last Decade
B Birkedal‐Hansen
22 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Cancer Research 2.2k
- Periodontics 386
- Immunology and Allergy 433
- Hematology 752
- Oncology 1.2k
Countries citing papers authored by B Birkedal‐Hansen
This map shows the geographic impact of B Birkedal‐Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Birkedal‐Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Birkedal‐Hansen more than expected).
Fields of papers citing papers by B Birkedal‐Hansen
This network shows the impact of papers produced by B Birkedal‐Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Birkedal‐Hansen. The network helps show where B Birkedal‐Hansen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside B Birkedal‐Hansen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 32 | |
| 2 | 2003 | 15 | |
| 3 | 2001 | 40 | |
| 4 | 2000 | 46 | |
| 5 | 1998 | 35 | |
| 6 | 1997 | 107 | |
| 7 | 1994 | 8 | |
| 8 | 1994 | 9 | |
| 9 | 1994 | 56 | |
| 10 | 1993 | 107 | |
| 11 | 1993 | 79 | |
| 12 | Matrix Metalloproteinases: A Reviewbreakdown → | 1993 | 2585 |
| 13 | A Mr 21,000 inhibitor of matrix metalloproteinases from human fibroblasts. | 1992 | 2 |
| 14 | Strategies for production of inhibitory monoclonal antibodies against matrix-degrading proteinases. | 1992 | 1 |
| 15 | Mr 95,000 metalloproteinase produced by rat mammary epithelial cells. | 1992 | 1 |
| 16 | Degradation of collagen fibrils by live cells: role of expression and activation of procollagenase. | 1992 | 10 |
| 17 | 1991 | 78 | |
| 18 | 1991 | 74 | |
| 19 | 1989 | 15 | |
| 20 | 1988 | 86 |
About B Birkedal‐Hansen
B Birkedal‐Hansen is a scholar working on Cancer Research, Pharmacy and Biotechnology, having authored 22 papers that have together received 3.4k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (19 papers), Peptidase Inhibition and Analysis (12 papers), Enzyme Production and Characterization (6 papers), Oral and gingival health research (5 papers), Bone and Dental Protein Studies (3 papers), Oral microbiology and periodontitis research (2 papers), Signaling Pathways in Disease (2 papers) and Connective tissue disorders research (2 papers). The work is most often cited by research in Cancer Research (2.2k citations), Periodontics (386 citations) and Immunology and Allergy (433 citations). B Birkedal‐Hansen has collaborated with scholars based in United States, Australia and Denmark. Frequent co-authors include Henning Birkedal‐Hansen, L. Jack Windsor, Malena Bodden, Jeffrey A. Engler, William G. I. Moore, Arthur A. DeCarlo, J. Guy Lyons, Gregory J. Harber, John M. Whitelock and Robert E. Taylor.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.